| Detection and localization of surgically resectable cancers with a multi-analyte blood test JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ... Science 359 (6378), 926-930, 2018 | 2388 | 2018 |
| Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma S Jones, TL Wang, IM Shih, TL Mao, K Nakayama, R Roden, R Glas, ... Science 330 (6001), 228-231, 2010 | 1426 | 2010 |
| Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles R Kirnbauer, J Taub, H Greenstone, R Roden, M Dürst, L Gissmann, ... Journal of virology 67 (12), 6929-6936, 1993 | 865 | 1993 |
| Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine CD Harro, YYS Pang, RBS Roden, A Hildesheim, Z Wang, MJ Reynolds, ... Journal of the National Cancer Institute 93 (4), 284-292, 2001 | 846 | 2001 |
| Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ... The American journal of pathology 179 (4), 1608-1615, 2011 | 565 | 2011 |
| Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model HL Greenstone, JD Nieland, KE De Visser, MLH De Bruijn, R Kirnbauer, ... Proceedings of the National Academy of Sciences 95 (4), 1800-1805, 1998 | 459 | 1998 |
| CD80 in Immune Suppression by Mouse Ovarian Carcinoma–Associated Gr-1+CD11b+ Myeloid Cells R Yang, Z Cai, Y Zhang, WH Yutzy IV, KF Roby, RBS Roden Cancer research 66 (13), 6807-6815, 2006 | 438 | 2006 |
| Increased plasma DNA integrity in cancer patients BG Wang, HY Huang, YC Chen, RE Bristow, K Kassauei, CC Cheng, ... Cancer research 63 (14), 3966-3968, 2003 | 428 | 2003 |
| How will HPV vaccines affect cervical cancer? R Roden, TC Wu Nature Reviews Cancer 6 (10), 753-763, 2006 | 423 | 2006 |
| Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers I Kinde, C Bettegowda, Y Wang, J Wu, N Agrawal, IM Shih, R Kurman, ... Science translational medicine 5 (167), 167ra4-167ra4, 2013 | 417 | 2013 |
| Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth Z Zhang, X Yang, Y Zhang, B Zeng, S Wang, T Zhu, RBS Roden, Y Chen, ... Clinical cancer research 12 (16), 4933-4939, 2006 | 397 | 2006 |
| In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype RB Roden, HL Greenstone, R Kirnbauer, FP Booy, J Jessie, DR Lowy, ... Journal of virology 70 (9), 5875-5883, 1996 | 387 | 1996 |
| Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 P Ramos, AN Karnezis, DW Craig, A Sekulic, ML Russell, WPD Hendricks, ... Nature genetics 46 (5), 427-429, 2014 | 350 | 2014 |
| Opportunities and challenges for human papillomavirus vaccination in cancer R Roden, PL Stern Nature Reviews Cancer 18 (4), 240-254, 2018 | 344 | 2018 |
| The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains PM Day, RBS Roden, DR Lowy, JT Schiller Journal of virology 72 (1), 142-150, 1998 | 324 | 1998 |
| L2, the minor capsid protein of papillomavirus JW Wang, RBS Roden Virology 445 (1-2), 175-186, 2013 | 312 | 2013 |
| Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype CL Trimble, S Piantadosi, P Gravitt, B Ronnett, E Pizer, A Elko, B Wilgus, ... Clinical cancer research 11 (13), 4717-4723, 2005 | 296 | 2005 |
| Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis RJ Kurman, K Visvanathan, R Roden, TC Wu, IM Shih American journal of obstetrics and gynecology 198 (4), 351-356, 2008 | 290 | 2008 |
| Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes RBS Roden, WH Yutzy IV, R Fallon, S Inglis, DR Lowy, JT Schiller Virology 270 (2), 254-257, 2000 | 290 | 2000 |
| Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia S Daayana, E Elkord, U Winters, M Pawlita, R Roden, PL Stern, ... British journal of cancer 102 (7), 1129-1136, 2010 | 277 | 2010 |
John T. SchillerNational Caner Institute, NIH在 mail.nih.gov 的电子邮件经过验证
